Home Cart 0 Sign in  

[ CAS No. 78056-39-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 78056-39-0
Chemical Structure| 78056-39-0
Structure of 78056-39-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 78056-39-0 ]

Related Doc. of [ 78056-39-0 ]

Alternatived Products of [ 78056-39-0 ]

Product Details of [ 78056-39-0 ]

CAS No. :78056-39-0 MDL No. :MFCD00010876
Formula : C6H4F2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :WDMCABATCGQAKK-UHFFFAOYSA-N
M.W : 174.11 Pubchem ID :157151
Synonyms :

Calculated chemistry of [ 78056-39-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.58
TPSA : 71.84 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 1.41
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 1.15
Log Po/w (SILICOS-IT) : -0.14
Consensus Log Po/w : 1.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.11
Solubility : 1.35 mg/ml ; 0.00773 mol/l
Class : Soluble
Log S (Ali) : -2.52
Solubility : 0.522 mg/ml ; 0.003 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.97
Solubility : 1.85 mg/ml ; 0.0106 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.02

Safety of [ 78056-39-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 78056-39-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 78056-39-0 ]
  • Downstream synthetic route of [ 78056-39-0 ]

[ 78056-39-0 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 2105-61-5 ]
  • [ 78056-39-0 ]
YieldReaction ConditionsOperation in experiment
12% With ammonia In methanol at 70℃; for 1.5 h; Microwave irradiation To a solution of 1,2,4-trifluoro-5-nitrobenzene (1) (5.00 g, 28.0 mmol, 1.00 equiv) in methanol (5 mL) was added methanolic ammonia (15 mL) and taken in microwave vial.
The reaction mixture was heated in microwave at 70° C. for 90 min.
The reaction mixture was cooled to RT and removed the solvent from the reaction under reduced pressure to give crude; which was purified by silica gel column chromatography (EtOAc/Hexane 1:4) to furnish compound 2 (0.600 g, 12.0percent) as yellow solid. TLC: 30percent EtOAc/Hexane (Rf: 0.35); 1H NMR (500 MHz, CDCl3): δ 8.00 (t, J=9.0 Hz, 1H), 6.65-6.58 (m, 1H), 6.08 (br s, 2H).
Reference: [1] Patent: US2013/287686, 2013, A1, . Location in patent: Paragraph 0144; 0145
[2] Journal of Medicinal Chemistry, 1965, vol. 8, p. 737 - 740
[3] Patent: US2018/185362, 2018, A1, . Location in patent: Paragraph 0556; 0557; 0558; 0559
  • 2
  • [ 458-11-7 ]
  • [ 78056-39-0 ]
Reference: [1] Journal of Fluorine Chemistry, 2003, vol. 121, # 2, p. 171 - 175
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 3, p. 369 - 374
[3] Heterocycles, 1995, vol. 41, # 10, p. 2203 - 2220
[4] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1786 - 1792
[5] Chemical and Pharmaceutical Bulletin, 1989, vol. 37, # 6, p. 1517 - 1523
[6] Patent: US4855292, 1989, A,
[7] Patent: US4874764, 1989, A,
[8] Patent: US4880806, 1989, A,
  • 3
  • [ 329939-78-8 ]
  • [ 78056-39-0 ]
Reference: [1] Patent: WO2005/123737, 2005, A2, . Location in patent: Page/Page column 119
  • 4
  • [ 1662-21-1 ]
  • [ 78056-39-0 ]
Reference: [1] Heterocycles, 1995, vol. 41, # 10, p. 2203 - 2220
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 3, p. 369 - 374
[3] Chemical and Pharmaceutical Bulletin, 1989, vol. 37, # 6, p. 1517 - 1523
[4] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1786 - 1792
[5] Patent: US4791225, 1988, A,
[6] Patent: US4788320, 1988, A,
[7] Patent: US4252954, 1981, A,
[8] Patent: US4264600, 1981, A,
[9] Patent: EP230946, 1988, A3,
  • 5
  • [ 3863-11-4 ]
  • [ 78056-39-0 ]
Reference: [1] Journal of Fluorine Chemistry, 2003, vol. 121, # 2, p. 171 - 175
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 3, p. 369 - 374
[3] Heterocycles, 1995, vol. 41, # 10, p. 2203 - 2220
[4] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1786 - 1792
  • 6
  • [ 85686-97-1 ]
  • [ 78056-39-0 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 102, p. 100532 - 100545
  • 7
  • [ 78056-39-0 ]
  • [ 76179-40-3 ]
YieldReaction ConditionsOperation in experiment
98% With hydrogen In methanol for 3 h; 4,5-Difluoro-2-nitro-aniline (10 g, 57 mmol) and 10percent palladium on carbon (2.0 g, 1.9 mmol) were placed in methanol (150 mL). The mixture was hydrogenated at 50 psi in a hydrogenator. After 3 hours the reaction mixture was filtered through diatomaceous earth and concentrated to a solid which was dried overnight (8.05 g, 98percent).
97% With palladium on activated charcoal; hydrogen In methanol at 20℃; for 12 h; Step 1: A mixture of 4,5-difluoro-2-nitroaniline (1.73 g, 10 mmol), palladium on activated charcoal (200 mg),and MeOH (50 mL) was stirred under hydrogen (1 atm) at rt for 12 h. The mixture was filtered to remove the catalystand the filtrate was concentrated under reduced pressure to afford 4,5-difluorobenzene-1,2-diamine (1.42 g, 97percent) as abrown solid, which was not purified further. 1H NMR (300 MHz, CDCl3) δ 6.50 (m, 2H), 2.75 - 3.48 (br s, 4H).
62% With tin(ll) chloride In ethanol at 20℃; for 0.5 h; Heating / reflux A mixture of 4,5-difluoro-2- nitro-phenylamine (10.00 g, 57.46 mmol) and tin(II) chloride dihydrate (64.83 g, 287.32 mmol) in ethanol (100 mL) was heated to reflux under nitrogen atmosphere for 30 min. After mixture was cooled down to room temperature, the pH of the solution was made basic (10 to 12) by addition of 5percent of sodium hydroxide solution. The solution was extracted with ethyl acetate. The combined organic layer was dried over magnesium sulfate. Solvent was removed under reduced pressure and the residue was crystallized in hexane to give a white solid (6.05 g, 62percent). 1H NMR (300 MHz, CDC13): 6 6.53 (t, J= 8.5 Hz, 2H), 3.38 (br, 4H). HRMS: Calcd. For C6H6F2N2 144.0499, Found 144.0500.
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 3, p. 331 - 342
[2] Patent: US2005/43292, 2005, A1, . Location in patent: Page/Page column 14
[3] Patent: EP2766359, 2016, B1, . Location in patent: Paragraph 0755
[4] Journal of Medicinal Chemistry, 1997, vol. 40, # 5, p. 811 - 818
[5] Russian Journal of Organic Chemistry, 2001, vol. 37, # 4, p. 564 - 569
[6] Angewandte Chemie - International Edition, 2011, vol. 50, # 13, p. 2995 - 2998
[7] Chemistry of Materials, 2012, vol. 24, # 16, p. 3247 - 3254
[8] Journal of the American Chemical Society, 2013, vol. 135, # 45, p. 17060 - 17068
[9] Journal of Materials Chemistry A, 2013, vol. 1, # 48, p. 15535 - 15543
[10] Patent: WO2005/123737, 2005, A2, . Location in patent: Page/Page column 119
[11] Chemical and Pharmaceutical Bulletin, 1989, vol. 37, # 6, p. 1517 - 1523
[12] Journal of Medicinal Chemistry, 1995, vol. 38, # 22, p. 4367 - 4379
[13] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
[14] Farmaco, 1998, vol. 53, # 7, p. 455 - 461
[15] Patent: US2005/20606, 2005, A1, . Location in patent: Page 8
[16] Patent: WO2005/123737, 2005, A2, . Location in patent: Page/Page column 111
[17] Patent: EP1627875, 2006, A1, . Location in patent: Page/Page column 10-11
[18] Patent: US6413938, 2002, B1,
[19] Patent: US5631373, 1997, A,
[20] Patent: US6204249, 2001, B1,
[21] Journal of Heterocyclic Chemistry, 2009, vol. 46, # 5, p. 936 - 948
[22] Patent: WO2006/108103, 2006, A1, . Location in patent: Page/Page column 28-29
[23] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1156 - 1159
[24] Synthesis (Germany), 2013, vol. 45, # 2, p. 272 - 280
[25] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
[26] Dalton Transactions, 2015, vol. 44, # 40, p. 17453 - 17461
[27] Patent: US2018/185362, 2018, A1, . Location in patent: Paragraph 0556; 0560; 0561; 0562
[28] Patent: US5514680, 1996, A,
[29] Patent: US2008/119496, 2008, A1, . Location in patent: Page/Page column 9
[30] Patent: WO2008/60301, 2008, A1, . Location in patent: Page/Page column 27-28
[31] Patent: WO2007/135527, 2007, A2, . Location in patent: Page/Page column 69-70
  • 8
  • [ 78056-39-0 ]
  • [ 7439-89-6 ]
  • [ 76179-40-3 ]
YieldReaction ConditionsOperation in experiment
77% With hydrogenchloride In methanol 4,5-Difluoro-1,2-phenylenediamine (10)
To a solution of 5.55 g (31.876 mmole) of 4,5-difluoro-2-nitroaniline in 50 mL of MeOH, were added 100 mL of 2 N HCl and 8.90 g (159.380 mmole) of iron powder.
The reaction mixture was stirred at room temperature for 2 hr and then filtered.
The filtrate was neutralized with conc. NH4 OH to ~pH 8.
The resulting suspension was filtered again and the filter cake was washed thoroughly with MeOH.
The filtrate and washings were combined, concentrated to ~100 mL, and extracted with CHCl3 (100 mL*3).
The CHCl3 solution was washed with a sat. NaCl solution (100 mL*2), dried (Na2 SO4), and evaporated.
The residue was coevaporated with CHCl3 to give 3.515 g (77percent) of 10.
This material was used in the next reaction without further purification.
A brown crystalline sample of 10 was obtained by recrystallization from CCl4. 1 H NMR (DMSO-d6): d6.44 (t, 2,3-H and 6-H, JF-H =10.5 H), 4.59 (br. s, 4,2*NH2).
Reference: [1] Patent: US5360795, 1994, A,
  • 9
  • [ 78056-39-0 ]
  • [ 91895-29-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 22, p. 4367 - 4379
[2] Patent: US5514680, 1996, A,
  • 10
  • [ 78056-39-0 ]
  • [ 78581-99-4 ]
Reference: [1] Synthesis (Germany), 2013, vol. 45, # 2, p. 272 - 280
[2] Patent: EP2766359, 2016, B1,
[3] Patent: US2008/119496, 2008, A1,
[4] Patent: WO2008/60301, 2008, A1,
  • 11
  • [ 24424-99-5 ]
  • [ 78056-39-0 ]
  • [ 1000698-88-3 ]
Reference: [1] Patent: WO2008/643, 2008, A1, . Location in patent: Page/Page column 118
[2] Patent: US2009/62356, 2009, A1, . Location in patent: Page/Page column 16-17
[3] Patent: US2009/131482, 2009, A1, . Location in patent: Page/Page column 14
  • 12
  • [ 78056-39-0 ]
  • [ 1293389-28-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2011, vol. 50, # 13, p. 2995 - 2998
[2] Journal of the American Chemical Society, 2013, vol. 135, # 45, p. 17060 - 17068
[3] Journal of Materials Chemistry A, 2013, vol. 1, # 48, p. 15535 - 15543
  • 13
  • [ 78056-39-0 ]
  • [ 1295502-53-2 ]
Reference: [1] Journal of Materials Chemistry A, 2013, vol. 1, # 48, p. 15535 - 15543
  • 14
  • [ 78056-39-0 ]
  • [ 1450590-76-7 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 45, p. 17060 - 17068
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 78056-39-0 ]

Fluorinated Building Blocks

Chemical Structure| 2369-11-1

[ 2369-11-1 ]

5-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 364-78-3

[ 364-78-3 ]

4-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 369-34-6

[ 369-34-6 ]

3,4-Difluoronitrobenzene

Similarity: 0.92

Chemical Structure| 148416-38-0

[ 148416-38-0 ]

2,3,4-Trifluoro-6-nitroaniline

Similarity: 0.89

Chemical Structure| 364-30-7

[ 364-30-7 ]

2,4-Difluoro-6-nitroaniline

Similarity: 0.89

Aryls

Chemical Structure| 2369-11-1

[ 2369-11-1 ]

5-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 364-78-3

[ 364-78-3 ]

4-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 369-34-6

[ 369-34-6 ]

3,4-Difluoronitrobenzene

Similarity: 0.92

Chemical Structure| 148416-38-0

[ 148416-38-0 ]

2,3,4-Trifluoro-6-nitroaniline

Similarity: 0.89

Chemical Structure| 364-30-7

[ 364-30-7 ]

2,4-Difluoro-6-nitroaniline

Similarity: 0.89

Amines

Chemical Structure| 2369-11-1

[ 2369-11-1 ]

5-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 364-78-3

[ 364-78-3 ]

4-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 148416-38-0

[ 148416-38-0 ]

2,3,4-Trifluoro-6-nitroaniline

Similarity: 0.89

Chemical Structure| 364-30-7

[ 364-30-7 ]

2,4-Difluoro-6-nitroaniline

Similarity: 0.89

Chemical Structure| 147285-87-8

[ 147285-87-8 ]

4-Fluoro-2-methyl-6-nitroaniline

Similarity: 0.86

Nitroes

Chemical Structure| 2369-11-1

[ 2369-11-1 ]

5-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 364-78-3

[ 364-78-3 ]

4-Fluoro-2-nitroaniline

Similarity: 0.96

Chemical Structure| 369-34-6

[ 369-34-6 ]

3,4-Difluoronitrobenzene

Similarity: 0.92

Chemical Structure| 148416-38-0

[ 148416-38-0 ]

2,3,4-Trifluoro-6-nitroaniline

Similarity: 0.89

Chemical Structure| 364-30-7

[ 364-30-7 ]

2,4-Difluoro-6-nitroaniline

Similarity: 0.89